Jarial Kush Dev Singh, Bhansali Anil, Gupta Vivek, Singh Paramjeet, Mukherjee Kanchan K, Sharma Akhilesh, Vashishtha Rakesh K, Sukumar Suja P, Sachdeva Naresh, Walia Rama
Department of EndocrinologyPost Graduate Institute of Medical Education and Research, Chandigarh, India.
Department of Radio-diagnosisPost Graduate Institute of Medical Education and Research, Chandigarh, India.
Endocr Connect. 2018 Mar;7(3):425-432. doi: 10.1530/EC-18-0046. Epub 2018 Feb 12.
Bilateral inferior petrosal sinus sampling (BIPSS) using hCRH is currently considered the 'gold standard' test for the differential diagnosis of ACTH-dependent Cushing's syndrome (CS). Vasopressin is more potent than CRH to stimulate ACTH secretion as shown in animal studies; however, no comparative data of its use are available during BIPSS.
To study the diagnostic accuracy and comparison of hCRH and lysine vasopressin (LVP) stimulation during BIPSS.
29 patients (27-Cushing's disease, 2-ectopic CS; confirmed on histopathology) underwent BIPSS and were included for the study. Patients were randomized to receive hCRH, 5 U LVP or 10 U LVP during BIPSS for ACTH stimulation. BIPSS and contrast-enhanced magnetic resonance imaging (CEMRI) were compared with intra-operative findings of trans-sphenoidal surgery (TSS) for localization and lateralization of the ACTH source.
BIPSS correctly localized the source of ACTH excess in 29/29 of the patients with accuracy of 26/26 patients, using any of the agent, whereas sensitivity and PPV for lateralization with hCRH, 5 U LVP and 10 U LVP was seen in 10/10, 6/10; 10/10,8/10 and 7/7,6/7 patients respectively. Concordance of BIPSS with TSS was seen in 20/27, CEMRI with BIPSS in 16/24 and CEMRI with TSS in 18/24 of patients for lateralizing the adenoma. Most of the side effects were transient and were comparable in all the three groups.
BIPSS using either hCRH or LVP (5 U or 10 U) confirmed the source of ACTH excess in all the patients, while 10 U LVP correctly lateralized the pituitary adenoma in three fourth of the patients.
目前,使用人促肾上腺皮质激素释放激素(hCRH)进行双侧岩下窦采血(BIPSS)被认为是促肾上腺皮质激素(ACTH)依赖性库欣综合征(CS)鉴别诊断的“金标准”检测方法。动物研究表明,血管加压素比CRH刺激ACTH分泌的作用更强;然而,在BIPSS期间使用血管加压素的比较数据尚无可用。
研究BIPSS期间hCRH和赖氨酸血管加压素(LVP)刺激的诊断准确性及比较情况。
29例患者(27例库欣病,2例异位CS;经组织病理学确诊)接受了BIPSS并纳入研究。患者在BIPSS期间接受hCRH、5 U LVP或10 U LVP随机分组以刺激ACTH分泌。将BIPSS和对比增强磁共振成像(CEMRI)与经蝶窦手术(TSS)术中ACTH来源的定位和侧别结果进行比较。
使用任何一种药物,BIPSS在29/29例患者中正确定位了ACTH过量来源,准确率为26/26例患者,而hCRH、5 U LVP和10 U LVP进行侧别的敏感性和阳性预测值分别见于10/10、6/10;10/10、8/10和7/7、6/7例患者。在20/27例患者中BIPSS与TSS结果一致,在16/24例患者中CEMRI与BIPSS结果一致,在18/24例患者中CEMRI与TSS结果一致用于腺瘤侧别。大多数副作用是短暂的,且在所有三组中相当。
使用hCRH或LVP(5 U或10 U)的BIPSS在所有患者中均证实了ACTH过量来源,而10 U LVP在四分之三的患者中正确侧别了垂体腺瘤。